2型糖尿病及并发冠心病患者高敏c反应蛋白水平的变化（Changes of high sensitivity C reactive protein levels in patients with type 2 diabetes mellitus complicated with coronary heart disease）.docVIP

2型糖尿病及并发冠心病患者高敏c反应蛋白水平的变化（Changes of high sensitivity C reactive protein levels in patients with type 2 diabetes mellitus complicated with coronary heart disease） High sensitivity C reactive protein water in patients with type 2 diabetes mellitus and complicated with coronary heart disease Flat change [Abstract] Objective: To investigate the abnormal glucose metabolism in obese and non obese patients with type 2 diabetes mellitus (T2DM) Is there a comparison between the inflammatory mechanism and the changes in high-sensitivity C reactive protein (hsCRP) in patients with coronary heart disease? There are different pathogenesis bases. Methods: a total of 120 patients with type 2 sugar were selected according to the criteria of clinical diagnosis Patients with diabetes, according to body mass index (BMI) were divided into obese group 60 cases (BMIs 25kg/m2) and non obese There were 60 cases (BMI25kg/m2). Serum hsCRP values were measured by ELISA. Result: The hsCRP and 7JC levels in obesity group were significantly higher than those in non obesity group (1.73 soil 1.27mg/L, VS) 1.21 soil 0.91mg/L, P= 0.03) hsCRP levels in obese patients with CHD are higher than those in T2DM patients Pure obesity was more pronounced in patients with T2DM (1.99 + 1.48mg/L vs, 1.55 + 1. 12mg/L, P=) 0.04). Conclusion: abnormal glucose metabolism and coronary disease may have common chronic subclinical inflammatory origin, inflammation It has important clinical value in predicting obesity associated with T2DM and macrovascular complications. Keywords diabetes mellitus; coronary heart disease; C reactive protein; Type 2 diabetes mellitus (T2DM) is closely related to coronary heart disease (CHD) in the course of clinical onset, and glucose metabolism syndrome (X Syndrome or insulin resistance syndrome is a precursor of type 2 diabetes mellitus. Obesity associated with type 2 diabetes mellitus Often accompanied by dyslipidemia, hypertension, hyperinsulinemia, hyperuricemia and other metabolic